This nomogram can be used by patients to estimate the risk of dying of prostate cancer if their cancer recurs, signaled by a rising PSA, after radical prostatectomy. The nomogram predicts the likelihood, in a man initially treated with surgery, that he will die of prostate cancer five, ten, and 15 years from the time his PSA begins to rise.
The information used to build this prediction tool was based on patients treated from 1987 to 2011. Since then, treatment for men with advanced prostate cancer has improved, so the risk of dying of the disease in the future may be less than estimated by this tool. Results produced by this tool are based on studies conducted at large research institutions with surgeons who perform a high volume of prostate cancer procedures. All results must be understood in the context of each patient’s specific treatment plan. Patients and caregivers using this tool should discuss the result with the patient’s physician.
To gather the information required to use this nomogram, use our worksheet.